Financing, Equity Capital Markets

Sutro Biopharma, Inc.

05/20
|
$85.3 Million
Piper Sandler served as bookrunner for Sutro Biopharma, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma